Cancer

May 28, 2019

Probiotic-based chemotherapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing a pharmacological formulation encompassing Metformin, Navitoclax/ABT-263, & Dasatinib (MND) and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as SOCS6, Gelsolin, p53, and TA-p73/p63, inhibits immune-inhibitory receptors/molecules, targets cancer stem cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 29/May/2019, 12.30 am

Probiotic-based chemotherapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing a pharmacological formulation encompassing Metformin, Navitoclax/ABT-263, & Dasatinib (MND) and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as SOCS6, Gelsolin, p53, and TA-p73/p63, inhibits immune-inhibitory receptors/molecules, targets cancer stem cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 29/May/2019, 12.30 am https://genomediscovery.org/wp-content/uploads/2019/05/A-pharmaceutical-mixture-encompassing-MND-and-the-probiotic-Lactobacillus-fn-as-an-anticancer-through-induction-of-Socs6-and-others.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/05/A-pharmaceutical-mixture-encompassing-MND-and-the-probiotic-Lactobacillus-fn-as-an-anticancer-through-induction-of-Socs6-and-others.jpg May 28, 2019 May 28, 2019

What we say: On the foundation of this interesting finding, Dr L Boominathan PhD, the Director-cum-chief Scientist of GBMD, reports that: Probiotic-based chemotherapy targeting cancer stem cells and immune-inhibitory receptors in…

May 28, 2019

Probiotic-based chemotherapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing a pharmacological formulation encompassing Metformin, Navitoclax/ABT-263, & Dasatinib (MND) and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as Nav3, SMARCA4, p53, and TA-p73/p63, inhibits immune-inhibitory receptors/molecules, targets cancer stem cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 29/May/2019, 12.17 am

Probiotic-based chemotherapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing a pharmacological formulation encompassing Metformin, Navitoclax/ABT-263, & Dasatinib (MND) and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as Nav3, SMARCA4, p53, and TA-p73/p63, inhibits immune-inhibitory receptors/molecules, targets cancer stem cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 29/May/2019, 12.17 am https://genomediscovery.org/wp-content/uploads/2019/05/A-pharmaceutical-mixture-encompassing-MND-and-the-probiotic-Lactobacillus-fn-as-an-anticancer-through-induction-of-NAV3-SMARCA4-and-others.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/05/A-pharmaceutical-mixture-encompassing-MND-and-the-probiotic-Lactobacillus-fn-as-an-anticancer-through-induction-of-NAV3-SMARCA4-and-others.jpg May 28, 2019 May 28, 2019

May 19, 2019

Natural sugar-based therapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing a pharmacological formulation encompassing Xylobiose (a disaccharide of xylose, with a a beta-1,4-bond), and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as SOCS6, APAF1, E-cadherin, p53, and TA-p73/p63, stalls cell cycle progression, inhibits immune-inhibitory receptors/molecules, suppresses cancer stem cell proliferation, inhibits migration, invasion and metastasis of cancer cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 20/May/2019, 12.47 am

Natural sugar-based therapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing a pharmacological formulation encompassing Xylobiose (a disaccharide of xylose, with a a beta-1,4-bond), and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as SOCS6, APAF1, E-cadherin, p53, and TA-p73/p63, stalls cell cycle progression, inhibits immune-inhibitory receptors/molecules, suppresses cancer stem cell proliferation, inhibits migration, invasion and metastasis of cancer cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 20/May/2019, 12.47 am https://genomediscovery.org/wp-content/uploads/2019/05/A-pharmaceutical-mixture-encompassing-Xylobiose-and.or-the-probiotic-Lactobacillus-increase-the-expression-of-tumor-supp.-Socs6-APAF1-and-others-and-attenuate-tumor-progression.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/05/A-pharmaceutical-mixture-encompassing-Xylobiose-and.or-the-probiotic-Lactobacillus-increase-the-expression-of-tumor-supp.-Socs6-APAF1-and-others-and-attenuate-tumor-progression.jpg May 19, 2019 May 19, 2019

What we say: On the foundation of this interesting finding, Dr L Boominathan PhD, the Director-cum-chief Scientist of GBMD, reports that: Natural sugar-based therapy targeting cancer stem cells and immune-inhibitory receptors…

May 16, 2019

Natural product-based therapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing Carvacrol, and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as TPM1, CADM1/2, E-cadherin, p53, and TA-p73/p63, stalls cell cycle progression, inhibits immune-inhibitory receptors/molecules, suppresses cancer stem cell proliferation, inhibits migration, invasion and metastasis of cancer cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 16/May/2019, 10.52 pm

Natural product-based therapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing Carvacrol, and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as TPM1, CADM1/2, E-cadherin, p53, and TA-p73/p63, stalls cell cycle progression, inhibits immune-inhibitory receptors/molecules, suppresses cancer stem cell proliferation, inhibits migration, invasion and metastasis of cancer cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 16/May/2019, 10.52 pm https://genomediscovery.org/wp-content/uploads/2019/05/A-pharmaceutical-mixture-encompassing-Carvacrol-and-the-probiotic-Lactobacillus-increases-the-exp.-of-TPM1-and-CADM1.2.jpg2_.jpg3_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/05/A-pharmaceutical-mixture-encompassing-Carvacrol-and-the-probiotic-Lactobacillus-increases-the-exp.-of-TPM1-and-CADM1.2.jpg2_.jpg3_.jpg May 16, 2019 May 16, 2019

What we say: On the foundation of this interesting finding, Dr L Boominathan PhD, the Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy targeting cancer stem cells and immune-inhibitory receptors…

May 14, 2019

Natural sugar-based therapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing a pharmacological formulation encompassing Xylobiose (a disaccharide of xylose, with a a beta-1,4-bond), and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as HNF4α, CDK2AP1, E-cadherin, p53, and TA-p73/p63, stalls cell cycle progression, inhibits immune-inhibitory receptors/molecules, suppresses cancer stem cell proliferation, inhibits migration, invasion and metastasis of cancer cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 14/May/2019, 10.40 am

Natural sugar-based therapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing a pharmacological formulation encompassing Xylobiose (a disaccharide of xylose, with a a beta-1,4-bond), and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as HNF4α, CDK2AP1, E-cadherin, p53, and TA-p73/p63, stalls cell cycle progression, inhibits immune-inhibitory receptors/molecules, suppresses cancer stem cell proliferation, inhibits migration, invasion and metastasis of cancer cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 14/May/2019, 10.40 am https://genomediscovery.org/wp-content/uploads/2019/05/Xylobiose-functions-as-an-antitumor.metastasis-agent-by-increasing-the-expression-of-tumor.metastasis-suppressors-including-HNF4a-p53-21-TAp73-p63-and-INK4a-ARF.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/05/Xylobiose-functions-as-an-antitumor.metastasis-agent-by-increasing-the-expression-of-tumor.metastasis-suppressors-including-HNF4a-p53-21-TAp73-p63-and-INK4a-ARF.jpg2_.jpg May 14, 2019 May 14, 2019

May 8, 2019

Treating cancers with longevity-promoting agents: Anticancer agent Bexarotene functions as a longevity-promoting agent: Bexarotene inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, via up regulation of its target gene, 8/May/2019, 7.13 am

Treating cancers with longevity-promoting agents: Anticancer agent Bexarotene functions as a longevity-promoting agent: Bexarotene inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, via up regulation of its target gene, 8/May/2019, 7.13 am https://genomediscovery.org/wp-content/uploads/2019/05/Bexarotene-extends-lifespan-by-decreasing-p70S6-Kinase-expression-and-by-increasing-the-expression-of-a-number-of-longevity-promoting-genes.jpg 1280 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/05/Bexarotene-extends-lifespan-by-decreasing-p70S6-Kinase-expression-and-by-increasing-the-expression-of-a-number-of-longevity-promoting-genes.jpg May 8, 2019 May 11, 2019

What they say? A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1…

Treating cancers with longevity-promoting agents: Anticancer agent Bexarotene functions as a longevity-promoting agent: Bexarotene inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, via up regulation of its target gene, 8/May/2019, 7.13 am

Popular Post